Antibody news from FierceBioResearcher
NewsFoundation invests millions to find MS drug leads
The Myelin Repair Foundation has spent $10 million so far to identify 18 new drug leads for multiple sclerosis. The non-profit foundation says it plans to roll out the two best leads to pharma Read more...
Mass spectrometry helps ID two MS drugs
There's a new target for drug developers focused on multiple sclerosis--and a pair of approved drugs that may already work against the disease. Using mass spectrometry, a team of researchers at Read more...
Antibody stimulates natural repair of MS damage
Low doses of a human antibody in mice were effective in repairing damaged myelin, a protective shield for nerves that is destroyed by multiple sclerosis. Read more...
| Press ReleasesPRESS RELEASE: PDL BioPharma Announces Significant Strategic and Portfolio Changes PDL BioPharma Announces Significant Strategic and Portfolio Changes to Focus on Antibody Discovery and Development - Company Plans Sale of Commercial Operations - FREMONT, Calif., Aug. 28 -- PDL Read more... |
Get more Antibody coverage at:
Paid Research Reports
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets